Howard L. Fields

Howard L. Fields

Auto-generated profile, based on publicly available information

Howard L. Fields

Department of Neurology, The Wheeler Center for the Neurobiology of Addiction, Alcoholism and Addiction Research Group, University of California, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Trends in Neurosciences
Verified
Journal Article
Closed access
HFHoward L. Fields
Howard L. Fields
EMElyssa B. Margolis
Elyssa B. Margolis

6 May 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
ENEdita Navratilova
Edita Navratilova
JXJennifer Yanhua Xie
Jennifer Yanhua Xie
DMDiana Meske
Diana Meske
CQChaoling Qu
Chaoling Qu
KMKozo Morimura
Kozo Morimura
FPFrank Porreca
Frank Porreca
Pain is aversive, and its relief elicits reward mediated by dopaminergic signaling in the nucleus accumbens (NAc), a part of the mesolimbic reward motivation pathway. How the reward pathway is engaged by pain-relieving treatments is not known. Endogenous opioid signaling in the anterior cingulate cortex (ACC), an area encoding pain aversiveness, contributes to pain modulation. We examined whether endogenous ACC opioid neurotransmission is required for relief of pain and subsequent downstream activation of NAc dopamine signaling. Conditioned place preference (CPP) andin vivomicrodialysis were used to assess negative reinforcement and NAc dopaminergic transmission. In rats with postsurgical or neuropathic pain, blockade of opioid signaling in the rostral ACC (rACC) inhibited CPP and NAc dopamine release resulting from non-opioid pain-relieving treatments, including peripheral nerve block or spinal clonidine, an α2-adrenergic agonist. Conversely, pharmacological activation of rACC opioid receptors of injured, but not pain-free, animals was sufficient to stimulate dopamine release in the NAc and produce CPP. In neuropathic, but not sham-operated, rats, systemic doses of morphine that did not affect withdrawal thresholds elicited CPP and NAc dopamine release, effects that were prevented by blockade of ACC opioid receptors. The data provide a neural explanation for the preferential effects of opioids on pain affect and demonstrate that engagement of NAc dopaminergic transmission by non-opioid pain-relieving treatments depends on upstream ACC opioid circuits. Endogenous opioid signaling in the ACC appears to be both necessary and sufficient for relief of pain aversiveness.

1 June 2016 in Neuron
Verified
Journal Article
Closed access
JRJocelyn M. Richard
Jocelyn M. Richard
FAFrederic Ambroggi
Frederic Ambroggi
PJPatricia H. Janak
Patricia H. Janak
HFHoward L. Fields
Howard L. Fields

29 October 2014 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EMElyssa Margolis
Elyssa Margolis
GHGregory O. Hjelmstad
Gregory O. Hjelmstad
WFWakako Fujita
Wakako Fujita
HFHoward L. Fields
Howard L. Fields
The ventral tegmental area (VTA) is required for the rewarding and motivational actions of opioids and activation of dopamine neurons has been implicated in these effects. The canonical model posits that opioid activation of VTA dopamine neurons is indirect, through inhibition of GABAergic inputs. However, VTA dopamine neurons also express postsynaptic μ-opioid peptide (MOP) receptors. We report here that in Sprague Dawley rat, the MOP receptor-selective agonist DAMGO (0.5–3 μm) depolarized or increased the firing rate of 87 of 451 VTA neurons (including 22 of 110 dopamine neurons). This DAMGO excitation occurs in the presence of GABAAreceptor blockade and its EC50value is two orders of magnitude lower than for presynaptic inhibition of GABA release on to VTA neurons. Consistent with a postsynaptic channel opening, excitations were accompanied by a decrease in input resistance. Excitations were blocked by CdCl2(100 μm,n= 5) and ω-agatoxin-IVA (100 nm,n= 3), nonselective and Cav2.1 Ca2+channel blockers, respectively. DAMGO also produced a postsynaptic inhibition in 233 of 451 VTA neurons, including 45 of 110 dopamine neurons. The mean reversal potential of the inhibitory current was −78 ± 7 mV and inhibitions were blocked by the K+channel blocker BaCl2(100 μm,n= 7). Blockade of either excitation or inhibition unmasked the opposite effect, suggesting that MOP receptors activate concurrent postsynaptic excitatory and inhibitory processes in most VTA neurons. These results provide a novel direct mechanism for MOP receptor control of VTA dopamine neurons.

9 August 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
HYHongbin Yang
Hongbin Yang
JJJohannes W. de Jong
Johannes W. de Jong
ICIgnas Cerniauskas
Ignas Cerniauskas
JPJames R. Peck
James R. Peck
BLByung Kook Lim
Byung Kook Lim
SLStephan Lammel
Stephan Lammel

5 February 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
YCYanxia Chen
Yanxia Chen
AMAubin Moutal
Aubin Moutal
ENEdita Navratilova
Edita Navratilova
CKCaroline Kopruszinski
Caroline Kopruszinski
XYXu Yue
Xu Yue
FPFrank Porreca
Frank Porreca
Female selective nociceptor sensitization and opioid-induced hyperalgesia result from an imbalance of prolactin receptor isoforms.